Literature DB >> 14713719

Oral tolerance.

Henry Yim Wu1, Howard L Weiner.   

Abstract

Autoimmune conditions caused by injurious immune responses against self-antigens can be ameliorated if the inappropriate responses to self-components that cause tissue injury can be modulated by regulatory cells or shut off via the induction of anergy or via deletion of pathogenic immune responses. Antigen encounter at the gut mucosa can lead to suppression of injurious immune responses to self-antigen via these mechanisms. This type of immunological event is termed oral tolerance. In this review, we examine the mechanisms behind the induction of oral tolerance and provide findings from its use as a form of treatment for autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14713719     DOI: 10.1385/IR:28:3:265

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  135 in total

1.  Anergic T cells act as suppressor cells in vitro and in vivo.

Authors:  J G Chai; I Bartok; P Chandler; S Vendetti; A Antoniou; J Dyson; R Lechler
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

2.  Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.

Authors:  C Aspord; C Thivolet
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

3.  Intradermal testing and sublingual desensitization for nickel.

Authors:  D L Morris
Journal:  Cutis       Date:  1998-03

Review 4.  Autoimmunity, microbial immunity and the immunological homunculus.

Authors:  I R Cohen; D B Young
Journal:  Immunol Today       Date:  1991-04

5.  Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite.

Authors:  G K Scadding; J Brostoff
Journal:  Clin Allergy       Date:  1986-09

6.  Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats.

Authors:  H S Thompson; N A Staines
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

7.  Oral immunotherapy in birch pollen hay fever.

Authors:  E Taudorf; L C Laursen; A Lanner; B Björksten; S Dreborg; M Søborg; B Weeke
Journal:  J Allergy Clin Immunol       Date:  1987-08       Impact factor: 10.793

8.  Breast feeding and maternal-donor renal allografts. Possibly the original donor-specific transfusion.

Authors:  D A Campbell; M I Lorber; J C Sweeton; J G Turcotte; J E Niederhuber; A E Beer
Journal:  Transplantation       Date:  1984-04       Impact factor: 4.939

9.  Effects of oral administration of type II collagen on rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius-Trentham; E J Orav; D Combitchi; C Lorenzo; K L Sewell; D A Hafler; H L Weiner
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

10.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  21 in total

1.  Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant.

Authors:  Henry Yim Wu; Ruth Maron; Ann-Marcia Tukpah; Howard L Weiner
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

2.  Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease.

Authors:  Eran Israeli; Yaron Ilan
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

3.  Oral tolerance in the absence of naturally occurring Tregs.

Authors:  Daniel Mucida; Nino Kutchukhidze; Agustin Erazo; Momtchilo Russo; Juan J Lafaille; Maria A Curotto de Lafaille
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

Review 4.  Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: peripheral versus in situ immunoregulation.

Authors:  Margaret S Bynoe; Paula Bonorino; Christophe Viret
Journal:  J Neuroimmunol       Date:  2007-09-27       Impact factor: 3.478

Review 5.  Immunity by equilibrium.

Authors:  Gérard Eberl
Journal:  Nat Rev Immunol       Date:  2016-07-11       Impact factor: 53.106

Review 6.  Strategies of mucosal immunotherapy for allergic diseases.

Authors:  Yi-Ling Ye; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

7.  The effect of oral tolerance on the allergic airway response in younger and aged mice.

Authors:  Janette M Birmingham; Sangita Patil; Xiu-Min Li; Paula J Busse
Journal:  J Asthma       Date:  2013-01-09       Impact factor: 2.515

8.  Oral and nasal administration of chicken type II collagen suppresses adjuvant arthritis in rats with intestinal lesions induced by meloxicam.

Authors:  Yong-Qiu Zheng; Wei Wei; Yu-Xian Shen; Min Dai; Li-Hua Liu
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  Suppression of Th1 and Th17, but not Th2, responses in a CD8(+) T cell-mediated model of oral tolerance.

Authors:  P M Arnaboldi; F Roth-Walter; L Mayer
Journal:  Mucosal Immunol       Date:  2009-07-01       Impact factor: 7.313

Review 10.  Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?

Authors:  Henry Yim Wu
Journal:  Clin Immunol       Date:  2008-10-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.